Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study

BMC Nephrology

Carmine Zoccali¹  Giovanni Tripepi¹  Francesca Mallamaci¹  Roberta Aliotta¹  Rocco Tripepi¹  Giuseppe Enia¹  Vincenzo Panuccio¹ 

[1]CNR-IBIM Clinical Epidemiology and Physiopathology of Renal Diseases and Hypertension, Via vallone Petrara, 89124, Reggio Calabria, Italy

关键词: Inflammation;    TNF-alpha;    Hyperparathyroidism;    Dialysis;    CKD;    Bone fractures;   

Others  :  1083077
DOI  :  10.1186/1471-2369-13-134

 received in 2012-04-19, accepted in 2012-09-23,  发布年份 2012

【 摘 要 】

Background

Pro-inflammatory cytokines play a key role in bone remodeling. Inflammation is highly prevalent in CKD-5D patients, but the relationship between pro-inflammatory cytokines and fractures in CKD-5D patients is unclear. We studied the relationship between inflammatory cytokines and incident bone fractures in a cohort of CKD-5D patients.

Methods

In 100 CKD-5D patients (66 on HD, 34 on CAPD; males:63, females:37; mean age: 61 ± 15; median dialysis vintage: 43 months) belonging to a single renal Unit, we measured at enrolment bone metabolic parameters (intact PTH, bone and total alkaline phosphatase, calcium, phosphate) and inflammatory cytokines (TNF-α, IL-6, CRP). Patients were followed-up until the first non traumatic fracture.

Results

During follow-up (median: 74 months; range 0.5 -84.0) 18 patients experienced fractures. On categorical analysis these patients compared to those without fractures had significantly higher intact PTH (median: 319 pg/ml IQ range: 95–741 vs 135 pg/ml IQ: 53–346; p = 0.04) and TNF-α levels (median: 12 pg/ml IQ: 6.4-13.4 vs 7.8 pg/ml IQ: 4.6-11; p = 0.02). Both TNF-α (HR for 5 pg/ml increase in TNF-α: 1.62 95% CI: 1.05-2.50; p = 0.03) and intact PTH (HR for 100 pg/ml increase in PTH: 1.15 95% CI: 1.04-1.27; p = 0.005) predicted bone fractures on univariate Cox’s regression analysis. In restricted (bivariate) models adjusting for previous fractures, age, sex and other risk factors both PTH and TNF-α maintained an independent association with incident fractures.

Conclusions

In our bivariate analyses TNF-α was significantly associated with incident fractures. Analyses in larger cohorts and with adequate number of events are needed to firmly establish the TNF α -fracture link emerged in the present study.

【 授权许可】

   
2012 Panuccio et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gresham JL, Mason N, Prutz KG, Young EW, Pisoni RL: Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2006, 70:1358-1366.
• [2]Jadoul M: Towards the prevention of bone fractures in dialysed patients? Nephrol Dial Transplant 2007, 22:3377-3380.
• [3]Hruska KA, Teitelbaum SL: Renal osteodystrophy. N Engl J Med 1995, 333:166-174.
• [4]Rachner TD, Khosla S, Hofbauer C: Osteoporosis: now and the future. Lancet 2011, 377:1276-1287.
• [5]Hardy R, Cooper MS: Bone loss in inflammatory disorders. J Endocrinol 2009, 201:309-320.
• [6]Kimble RB, Bain S, Pacifici R: The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 1997, 12:935-941.
• [7]Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S: Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerinligand gene expression in human osteoblastic cells. Bone 1999, 25:255-259.
• [8]Lehouck A, Boonen S, Decramer M, Joanssens W: COPD, bone metabolism and osteoporosis. Chest 2011, 139:648-657.
• [9]Ali T, Lam D, Bronze MS, Humphrey MB: Osteoporosis in inflammartory bowel disease. Am J Med 2009, 122:599-604.
• [10]Cummings SR, San Martin J, McClung MR, et al.: for the FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009, 361:756-765.
• [11]Jamal SA, Ljunggren O, Stehman-Breen C, Cummings SR, McClung MR, Goemaere S, Ebeling PR, Franek E, Yang YC, Egbuna OI, Boonen S, Miller PD: Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res 2011, 26:1829-1835.
• [12]Stenvinkel P, Wanner C, Metzger T, Heimburger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C: Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? Kidney Int 2002, 62:1791-1798.
• [13]Paniagua R, Frias Y, de Ventura MJ, Rodriguez E, Hurtado ME, Alcantara G, Vazquez R, Ortiz R, Salcedo M, Rios ME, Kaji J, Amato D: C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis. Perit Dial Int 2003, 23:132-137.
• [14]Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM, Campbell SB, Sturtevant JM, Isbel NM, Nicol DL, Johnson DW: Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 2001, 12:814-821.
• [15]Meuwese CL, Snaedal S, Halbesma N, Stenvinkel P, Dekker FW, Qureshi AR, Barany P, Heimburger O, Lindholm B, Krediet RT, Boeschoten EW, Carrero JJ: Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-α are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant 2011, 26:1313-1318.
• [16]Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E: Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial Infarction. Circulation 2000, 101:2149-2153.
• [17]Genant HK, Wu CY, Van KuijK C, Nevitt MC: Vertebral Fracture Assessment Using a Semiquantitative Technique. J Bone Miner Res 1993, 8:1137-1148.
• [18]Goldsmith DJA, Covic A, Fouque D, Locatelli F, Olgaard K, Rodriguez M, Spasovski G, Urena P, Zoccali C, London GM, Vanholder R: Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement. Nephrol Dial Transplant 2010, 25:3823-3831.
• [19]Miettinen OS: Stratification by a multivariate confounder score. Am J Epidemiol 1976, 104:609-620.
• [20]D'Amelio P, Grimaldi A, Di Bella S, Brianza SZ, Cristofaro MA, Tamone C, Giribaldi G, Ulliers D, Pescarmona GP, Isaia G: Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 2008, 43:92-100.
• [21]Cauley JA, Danielson ME, Boudreau RM, Forrest KY, Zmuda JM, Pahor M, Tylavsky FA, Cummings SR, Harris TB, Newman AB: for the Health ABC Study. Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 2007, 22:1088-1095.
• [22]Barbour KE, Boudreau R, Danielson ME, Youk AO, Wactawski-Wende J, Greep NC, Lacroix AZ, Jackson RD, Wallace RB, Bauer DC, Allison MA, Cauley JA: Inflammatory markers and the risk of hip fracture: The women's health initiative. J Bone Miner Res 2012.
• [23]Ensrud KE, Barbour K, Canales MT, Danielson ME, Boudreau RM, Bauer DC, Lacroix AZ, Ishani A, Jackson RD, Robbins JA, Cauley JA: Renal function and nonvertebral fracture risk in multiethnic women: the Women's Health Initiative (WHI). Osteoporos Int 2012, 23(3):887-899. Epub 2011 May 28
• [24]Mittalhenkle A, Gillen DL, Stehman-Breen C: Increased Risk of Mortality Associated With Hip Fracture in the Dialysis Population. Am J Kidney Dis 2004, 44:672-679.